Generation of liver metastases in a mouse model using ultrasound-guided intravenous injection

Amanda Labora, Hailey R. Lee, Charlotte Chan, Erin Tabornal, Thuc Duy Le, Khalid T. Rashid, Evan R. Abt, Takanobu Yamao, Hanna K. Mandl, Amanda L. Creech, Alykhan Premji, Luyi Li, Jason S. Link, Nanping Wu, Caius G. Radu, Timothy R. DonahueSTAR 2023 · DOI

TL;DR

This paper presents a detailed protocol for generating a reliable mouse model of liver metastasis by precisely injecting tumor cells into the portal vein using ultrasound guidance. This method offers improved accuracy and reproducibility compared to traditional approaches, enabling better study of cancer progression and treatment efficacy.

What Problem Does This Paper Address?

Creating accurate and reproducible animal models of cancer metastasis is crucial for understanding disease progression and testing new therapies. Liver metastasis, a common and often fatal outcome of many cancers, is particularly challenging to model reliably. Traditional methods for inducing liver metastases in mice often lack precision, leading to variable outcomes and making it difficult to interpret experimental results. This paper addresses the need for a standardized, high-precision method to generate liver metastases, specifically by targeting the portal vein, which is the primary route for liver metastasis.

Methods

The core of this protocol lies in the ultrasound-guided intravenous injection technique. The authors detail a step-by-step process that includes:

  • Animal and Cell Preparation: Standard procedures for preparing mice and tumor cells for injection.
  • Ultrasound-Guided Injection: This is the key innovation. The protocol describes two methods for injecting tumor cells into the portal vein:
  • Freehand Technique: This involves skilled manipulation of a needle under real-time ultrasound visualization.
  • Device-Assisted Technique: The authors developed a 3D-printed prototype device to stabilize the syringe and needle, ensuring it remains in plane with the ultrasound probe. This device aims to improve precision and reduce the learning curve associated with the freehand method.
  • Tumor Surveillance: Bioluminescent Imaging (BLI) is used to monitor tumor growth and metastasis over time. This non-invasive technique allows for tracking the development of liver lesions.

The protocol emphasizes critical aspects like maintaining the needle "in plane" with the ultrasound probe for accurate visualization and injection, as well as proper anesthesia and animal handling to minimize stress and hypothermia.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • Precision is Paramount: The paper strongly emphasizes that precise needle placement within the portal vein is the most critical factor for successful liver metastasis modeling. Even minor deviations can lead to misinjection, vessel injury, or intraperitoneal seeding, compromising the model's validity.
  • The 3D-Printed Device is a Game-Changer: While the freehand technique is feasible, the development of a 3D-printed stabilization device is a significant contribution. It addresses the technical challenge of maintaining needle-in-plane alignment, making the procedure more accessible and reproducible, especially for less experienced users.
  • Ultrasound as a Real-Time Guide: The protocol highlights the power of real-time ultrasound imaging for identifying anatomical landmarks (spleen, splenic vein, portal vein) and guiding the needle with sub-millimeter accuracy.
  • Bioluminescence for Sensitive Monitoring: BLI provides a sensitive and non-invasive way to track the growth of even small metastatic lesions, allowing for the assessment of treatment efficacy and understanding of tumor kinetics.
  • Cell Line and Dose Optimization is Crucial: The authors note that the time to initial BLI signal and the development of visible metastases can vary significantly based on the cell line and the number of cells injected. This underscores the need for titration experiments to optimize the model for specific research questions.

Key Results

The protocol successfully generates liver metastases in mice using ultrasound-guided portal vein injection. The authors demonstrate variable growth kinetics of metastases using both B16F10-luc (melanoma) and HPAC-luc (pancreatic cancer) cell lines. They show representative BLI images over time, illustrating the development and progression of liver lesions. The protocol also provides detailed troubleshooting guidance for common issues encountered during the procedure, such as difficulty obtaining an injection window or maintaining the needle in plane.

Limitations and Future Work

  • Learning Curve: While the 3D-printed device aims to simplify the procedure, the freehand technique still requires significant skill and practice.
  • Cell Line Dependency: The growth kinetics and metastatic potential are highly dependent on the specific tumor cell line and the host mouse strain. Optimization experiments are necessary for each new model.
  • Reporter Gene Immunogenicity: The use of luciferase-expressing cell lines for BLI may introduce immunogenicity concerns, which could affect the tumor microenvironment. Alternative methods like IHC or PCR might be needed for endpoints if using unmodified cell lines.
  • Pancreatic Seeding: Given the transpancreatic approach to access the portal vein, occasional pancreatic seeding of tumor cells is not unexpected.
  • Future Work: The authors suggest that further optimization experiments are required to define growth kinetics for each specific model. The development of the 3D-printed device is also a key area of innovation that could be further refined or adapted.

Summary updated

Abstract

Here, we present a protocol to generate a murine model of liver metastasis by directly injecting tumor cells into the portal vein under ultrasound guidance. We describe steps for animal and cell preparation and two techniques for injecting tumor cells. One technique is freehand, while the other technique is device-assisted using a 3D-printed prototype device. Finally, we describe tumor surveillance with bioluminescent imaging.
BibTeX
@inproceedings{labora2023generation,
  author = {Amanda Labora and Hailey R. Lee and Charlotte Chan and Erin Tabornal and Thuc Duy Le and Khalid T. Rashid and Evan R. Abt and Takanobu Yamao and Hanna K. Mandl and Amanda L. Creech and Alykhan Premji and Luyi Li and Jason S. Link and Nanping Wu and Caius G. Radu and Timothy R. Donahue},
  title = {{Generation of liver metastases in a mouse model using ultrasound-guided intravenous injection}},
  booktitle = {STAR},
  year = {2023},
  doi = {10.1016/j.xpro.2023.102163},
}
Figure